These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 2529378)

  • 1. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
    Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
    J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.
    Kornuc M; Kliewer S; Garcia J; Harrich D; Li C; Gaynor R
    J Virol; 1990 May; 64(5):2004-13. PubMed ID: 2139139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
    Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein.
    Tsang SX; Morris GF; Lu M; Morris CB
    Oncogene; 1996 Feb; 12(4):819-26. PubMed ID: 8632904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple transcription factor binding sites mediate adenovirus E1A transactivation.
    Pei R; Berk AJ
    J Virol; 1989 Aug; 63(8):3499-506. PubMed ID: 2545919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A TATA box implicated in E1A transcriptional activation of a simple adenovirus 2 promoter.
    Wu L; Rosser DS; Schmidt MC; Berk A
    Nature; 1987 Apr 2-8; 326(6112):512-5. PubMed ID: 2951598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A.
    Spergel JM; Hsu W; Akira S; Thimmappaya B; Kishimoto T; Chen-Kiang S
    J Virol; 1992 Feb; 66(2):1021-30. PubMed ID: 1309887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site.
    Morris GF; Mathews MB
    J Virol; 1991 Dec; 65(12):6397-406. PubMed ID: 1682506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
    Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
    J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct DNA targets for trans-activation by HTLV-1 tax and adenovirus E1A.
    Nicholas J; Nevins JR
    Virology; 1991 May; 182(1):156-67. PubMed ID: 1827222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.
    Laspia MF; Rice AP; Mathews MB
    Genes Dev; 1990 Dec; 4(12B):2397-408. PubMed ID: 2149119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K.
    Schmitz ML; Indorf A; Limbourg FP; Städtler H; Traenckner EB; Baeuerle PA
    Mol Cell Biol; 1996 Aug; 16(8):4052-63. PubMed ID: 8754803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function.
    Venkatesh LK; Chinnadurai G
    J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.
    Song CZ; Loewenstein PM; Green M
    J Virol; 1995 May; 69(5):2907-11. PubMed ID: 7707515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins.
    White E; Cipriani R; Sabbatini P; Denton A
    J Virol; 1991 Jun; 65(6):2968-78. PubMed ID: 1851867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.